Frontlight ResearchEarly access
Trial site
The James Cancer Hospital and Solove Research Institute
- 11running trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Sarcoma3 trials
- Acute myeloid leukaemia2 trials
- Lung cancer2 trials
- Acute lymphoblastic leukaemia1 trial
- Bladder cancer1 trial
- Childhood cancers1 trial
- Chronic lymphocytic leukaemia1 trial
- Metastatic breast cancer1 trial
- Myelodysplastic syndromes1 trial
- Myeloproliferative neoplasms1 trial
- Phase
- Phase 36 trials
- Phase 12 trials
- Phase 1/22 trials
- Phase 21 trial
- Status
- Recruiting7 trials
- Active, not recruiting4 trials
- Lead sponsor
- Hoffmann-La Roche2 trials
- Swedish Orphan Biovitrum2 trials
- Celcuity Inc1 trial
- Daiichi Sankyo1 trial
- Intensity Therapeutics, Inc.1 trial
- and 4 more
Running trials
Recruiting
Recruiting
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
Recruiting
A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)
Active, not recruiting
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Sarcoma3 recruiting
- Lung cancer2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Acute myeloid leukaemia1 recruiting
- Bladder cancer1 recruiting
- Childhood cancers1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
Site data: ClinicalTrials.govUpdated 18 Nov 2026